A recent study investigating FGF23 and cardiovascular outcomes in a younger (aged 45 ± 4 years) patient cohort with few comorbidities found no associations between FGF23 and incident CAD, CAD events, and mortality, whereas elevated FGF23 was independently associated with a greater risk of hospitalization for HF [17]. Here, FGF23 is linked to hydrops fetalis.